-The Telegraph A group of eminent individuals has written to Prime Minister Manmohan Singh asking him to initiate a “truly inclusive process of deliberation” to help formulate a rational public policy on nuclear power and genetically modified (GM) crops. Justice V.R. Krishna Iyer, a former Supreme Court judge, and 16 others, including former scientists and administrators, have also questioned Singh’s remarks to a US journal last month suggesting that foreign non-government organisations...

Days after Prime Minister Manmohan Singh spoke of the role of foreign-funded NGOs in instigating protests against genetic engineering in agriculture, Rural Development Minister Jairam Ramesh has asserted that his controversial decision to put the release of genetically-modified brinjal on indefinite hold in 2010 was not influenced by any NGO.   As the then environment minister, Jairam had blocked the commercial release of Bt brinjal, citing a lack of scientific consensus and...

Genetic Engineering Appraisal Committee (GEAC), the apex authority for approval of large-scale field trials and commercialisation of GM crops, has decided to hold “dialogue” with state governments to iron out irritants being faced in the grant of no objection certificates (NOC) for GM crops’ trials. The development comes after the Centre’s Review Committee on Genetic Manipulation and GM seed industry association petitioned the GEAC regarding the delay or denial of NOC...

Maharashtra sounds clarion call on hybrid crop liability Competition is tough in the seed market, which may explain why marketing gimmicks are often used to woo farmers. It’s tougher still for the farmers to get compensation when the claims fail and they are saddled with a bad or damaged crop. Sometimes the state government steps in to offer compensation or the farmers turn to the consumer court for relief. Typically, of...

-The Economic Times   Vaccines are a true gift of science to humanity. In developing countries, prevention is better than cure. Vaccines have a great track record of safety and efficacy and they are amongst the most cost-effective products, which even the poor have access to due to effective systems of procurement and delivery. India's contribution in the vaccine arena is noteworthy. The primary reason behind the country's vaccine success story is...